Blood Transfusion Products Contain Mitochondrial DNA Damps: A Potential Effector Of Transfusion Related Acute Lung Injury

2014 ◽  
Vol 186 (2) ◽  
pp. 509 ◽  
Author(s):  
Y.L. Lee ◽  
M. King ◽  
M.N. Gillespie ◽  
R.P. Gonzalez ◽  
S.B. Brevard ◽  
...  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Jia-yu Mao ◽  
Dong-kai Li ◽  
Hong-min Zhang ◽  
Xiao-ting Wang ◽  
Da-wei Liu

Abstract Background Mitochondrial DNA (mtDNA) is a critical activator of inflammation. Circulating mtDNA released causes lung injury in experimental models. We hypothesized that elevated plasma mtDNA levels are associated with acute lung injury (ALI) in septic patients. Methods We enrolled 66 patients with sepsis admitted to the Department of Critical Care Medicine of Peking Union Medical College Hospital between January 2019 and October 2019. Respiratory, hemodynamic and bedside echocardiographic parameters were recorded. Plasma mtDNA, procalcitonin, interleukin 6, and interleukin 8 levels were examined. Results Plasma mtDNA levels within 24 h after admission were significantly increased in the group of septic patients with ALI [5.01 (3.38–6.64) vs 4.13 (3.20–5.07) log copies/µL, p 0.0172]. mtDNA levels were independently associated with mortality (hazard ratio, 3.2052; 95% CI 1.1608–8.8500; p 0.0253) and ALI risk (odds ratio 2.7506; 95% CI 1.1647–6.4959; p 0.0210). Patients with high mtDNA levels had worse outcomes, and post hoc tests showed significant differences in 28-day survival rates. Increased mtDNA levels were seen in patients with abdominal infection. Conclusions Increased plasma mtDNA levels within 24 h after admission were significantly associated with ALI incidence and mortality in septic patients.


2020 ◽  
Author(s):  
Lunyang Hu ◽  
Baoli Wang ◽  
Yong Jiang ◽  
Banghui Zhu ◽  
Chen Wang ◽  
...  

Abstract Background: Until now, transfusion-related acute lung injury (TRALI) has been considered to be the leading cause of blood transfusion-related diseases and death. And there is no clinically effective treatment plan for TRALI. The aim of this study was to systematically summarize the literature on risk factors for TRALI in critical patients. Methods: Electronic searches (up to March 2020) were performed in the Cochrane Library, Web of Knowledge, Embase, and PubMed databases. We included studies reporting on the risk factors of TRALI for critical patients and extracted the risk factors. Finally, third studies met the inclusion criteria. Results: We summarized and analyzed the potential risk factors of TRALI for critical patients in 13 existing studies. The host-related factors were age (odds ratio (OR) [95% confidence interval] = 1.16 [1.08-1.24]), sex (OR = 1.26 [1.16-1.38]), tobacco use status (OR = 3.82 [1.91-7.65]), chronic alcohol abuse (OR = 3.82 [2.97-26.83]), fluid balance (OR = 1.24 [1.08-1.42]), shock before transfusion (OR = 4.41 [2.38-8.20]), and ASA score of the recipients (OR = 2.72 [1.43-5.16]). The transfusion-related factors were the number of transfusions (OR = 1.40 [1.14-1.72]) and fresh frozen plasma (FFP) units (OR = 1.21 [1.01-1.46]). The device-related factor was mechanical ventilation (OR = 4.13 [2.20-7.76]). Conclusions: The risk factors for TRALI in this study included age, sex, tobacco use, chronic alcohol abuse, fluid balance, shock before transfusion, ASA score, number of transfusions, FFP units and mechanical ventilation. Our study suggests that host-related risk factors play a more important role in the occurrence and development of TRALI than blood transfusion-related risk factors.


2019 ◽  
Vol 11 (11) ◽  
pp. 4816-4828 ◽  
Author(s):  
Guannan Wu ◽  
Qingqing Zhu ◽  
Junli Zeng ◽  
Xiaoling Gu ◽  
Yingying Miao ◽  
...  

2014 ◽  
Vol 76 ◽  
pp. S167-S168
Author(s):  
Kirsten C Verhein ◽  
Jennifer L Nichols ◽  
Vijayalakshmi Panduri ◽  
Wesley Gladwell ◽  
Jacqui Marzec ◽  
...  

Transfusion ◽  
2004 ◽  
Vol 44 (10) ◽  
pp. 1468-1474 ◽  
Author(s):  
Ognjen Gajic ◽  
Rimki Rana ◽  
Jose L. Mendez ◽  
Otis B. Rickman ◽  
James F. Lymp ◽  
...  

2011 ◽  
Vol 115 (3) ◽  
pp. 635-649 ◽  
Author(s):  
Brian M. Gilliss ◽  
Mark R. Looney ◽  
Michael A. Gropper ◽  
David S. Warner

As screening for transfusion-associated infections has improved, noninfectious complications of transfusion now cause the majority of morbidity and mortality associated with transfusion in the United States. For example, transfusion-related acute lung injury, transfusion-associated circulatory overload, and hemolytic transfusion-reactions are the first, second, and third leading causes of death from transfusion, respectively. These complications and others are reviewed, and several controversial methods for prevention of noninfectious complications of transfusion are discussed, including universal leukoreduction of erythrocyte units, use of male-only plasma, and restriction of erythrocyte storage age.


2016 ◽  
Vol 17 (9) ◽  
pp. 1425 ◽  
Author(s):  
Lemeng Zhang ◽  
Songyun Deng ◽  
Shuangping Zhao ◽  
Yuhang Ai ◽  
Lina Zhang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document